Persisting effect of Ca2+-channel blockers on left ventricular function in hypertrophic cardiomyopathy after 14 years' treatment

Angiology

Volumn 47, Issue 8, 1996, Pages 765-774

  Hartmann, Andreas ^a   Schnell, Joachim ^b   Hopf, Rüdiger ^c   Kneissl, Georg ^a  

^a Klinikum St Georg   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c KRANKENHAUS SACHSENHAUSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; GALLOPAMIL; VERAPAMIL;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ERGOMETRY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0029737723     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979604700803     Document Type: Article

References (27)

1. Maron BJ, Bonow RO, Cannon RO, et al: Hypertrophic cardiomyopathy: Interrelations of clinical manifestations, pathphysiology and therapy. N Engl J Med 316:780-789, 844-852, 1987.
2. Kaltenbach M, Hopf R, Kober C, et al: Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J 42:35-42, 1979.
3. Bonow RO, Dilsizian V, Rosing DR, et al: Verapamil- induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term effects. Circulation 72:853-864, 1985.
4. Hopf R, Kaltenbach M: 10-year results and survival of patients with hypertrophic cardiomyopathy treated with calcium-antagonists. Z Kardiol 76(suppl 3): 137- 144, 1987.
5. Seiler C, Hess OM, Schoenbeck M, et al: Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: A retrospective study. J Am Coll Cardiol 17:634-642, 1991.
6. Hess OM, Murakami T, Krayenbühl HP: Does verapamil improve left ventricular relaxation in patients with myocardial hypertrophy? Circulation 74:530- 543, 1986.
7. Hopf R, Kaltenbach M: Management of hypertrophic cardiomyopathy. Ann Rev Med 41:75-83, 1990.
8. Maron BJ, Epstein SE: Hypertrophic cardiomyopathy: A discussion of nomenclature. Am J Cardiol 43:1242- 1244, 1979.
9. Maron BJ, Spirito P, Green KJ, et al: Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 10:733-742, 1987.
10. Iwase M, Sotobata I, Takagi S, et al: Effects of diltiazem on left ventricular diastolic behavior in patients with hypertrophic cardiomyopathy: Evaluation with exercise pulsed Doppler echocardiography. J Am Coll Cardiol 9:1099-1105, 1987.
11. Wigle ED, Heimbecker RO, Gunton RW: Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 26:325-340, 1962.
12. Stewart S, Mason DT, Braunwald E: Impaired rate of left ventricular filling in idiopathic hypertrophic subaortic stenosis and valvular aortic stenosis. Circulation 37:8-14, 1968.
13. Hess OM, Grimm J, Krayenbühl HP: Diastolic function in hypertrophic cardiomyopathy: Effects of propranolol and verapamil on diastolic stiffness. Eur Heart J 4(suppl F):47-56, 1983.
14. Paulus WJ, Lorell BH, Craig WE, et al: Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: Altered left ventricular loading or improved muscle inactivation? J Am Coll Cardiol 2:879- 886, 1983.
15. Sanderson JE, Gibson DG, Brown DJ, et al: Left ventricular filling in hypertrophic cardiomyopathy: An angiographic study. Br Heart J 39:661-670, 1977.
16. Bonow RO, Frederick TM, Bacharach SL, et al: Atrial systole and left ventricular filling in patients with hypertrophic cardiomyopathy: Effect of verapamil. Am J Cardiol 51:1386-1391, 1983.
17. Hanrath P, Mathey DG, Siegert R, et al: Left ventricular relaxation and filling in different forms of left ventricular hypertrophy: An echocardiographic study. Am J Cardiol 45:15-23, 1980.
18. Spirito P, Maron BJ: Relation between extent of left ventricular hypertrophy and diastolic filling abnormalities in hypertrophic cardiomyopathy. J Am Coll Cardiol 15:808-813, 1990.
19. Bonow RO, Ostrow HG, Rosing DR, et al: Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: Pressure-volume analysis with a nonimaging scintillation probe. Circulation 68:1062-1073, 1983.
20. Hanrath P, Mathey DG, Kremer P, et al: Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy. Am J Cardiol 45:1258-1264, 1980.
21. Udelson JE, Bonow RO, O'Gara PT, et al: Verapamil prevents silent myocardial perfusion abnormalities during exercise in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 79:1052- 1060, 1989.
22. Walsh RA, O'Rourke RA: Direct and indirect effects of calcium entry blocking agents on isovolumic relaxation in conscious dogs. J Clin Invest 75:1426- 1434, 1985.
23. Bonow RO, Vitale DF, Maron BJ, et al: Regional left ventricular asynchrony and impaired global left ventricular filling in hypertrophic cardiomyopathy: Effect of verapamil. J Am Coll Cardiol 9:1108-1116, 1987.
24. Maul FD, Hopf R, Hör G, et al: Radionuclide ventriculography: Acute and chronic response to verapamil in patients with hypertrophic cardiomyopathy. Z Kardiol 76(suppl 3):39-45, 1987.
25. Anderson DM, Raff GL, Ports TA, et al: Hypertrophic obstructive cardiomyopathy: Effects of acute and chronic verapamil treatment on left ventricular systolic and diastolic function. Br Heart J 51:523-529, 1984.
26. Nishimura R, Schwartz RS, Holmes DR, et al: Failure of calcium channel blockers to improve ventricular relaxation in humans. J Am Coll Cardiol 21:182-188, 1993.
27. Thomas JD: Doppler echocardiography and left ventricular diastolic function. In: Left Ventricular Diastolic Dysfunction and Heart Failure, ed. by Gaasch WH, LeWinter MM. Philadelphia: Lea and Febiger, 1994, pp 192-218.